Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

HLA-B*5701 typing by sequence-specific amplification: validation and comparison with sequence-based typing.

A M Martin1, D Nolan, S Mallal

  • 1Center for Clinical Immunology and Biomedical Genetics, Royal Perth Hospital and Murdoch University, Western Australia 6000. annalise.martin@health.wa.gov.au

Tissue Antigens
|May 18, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Toxicity related to immunotherapy in urothelial cancer: Tumour genetic risk variants.

The pharmacogenomics journal·2026
Same author

Tackling burnout in Australian doctors by blending a web-based cognitive-behavioural therapy program with telehealth psychological support - protocol for a three-arm randomised-controlled trial.

Contemporary clinical trials communications·2025
Same author

Real-world use of long-acting cabotegravir and rilpivirine: 12-month results of the inJectable Antiretroviral therapy feasiBility Study (JABS).

HIV medicine·2024
Same author

Quench dynamics of edge states in a finite extended Su-Schrieffer-Heeger system.

Physical review. E·2023
Same author

Development of in silico models to guide the experimental characterisation of penile tissue and inform surgical treatment of erectile dysfunction.

Computers in biology and medicine·2023
Same author

Host, environment, and anthropogenic factors drive landscape dynamics of an environmentally transmitted pathogen: Sarcoptic mange in the bare-nosed wombat.

The Journal of animal ecology·2023
Same journal

Corrigendum.

Tissue antigens·2015
Same journal

Nomenclature for factors of the HLA system, update September 2015.

Tissue antigens·2015
Same journal

Nomenclature for factors of the HLA system, update August 2015.

Tissue antigens·2015
Same journal

Nomenclature for factors of the HLA system, update July 2015.

Tissue antigens·2015
Same journal

Four amino acid exchanges located in the alpha-2 domain specify the novel HLA-B*50:20 allele.

Tissue antigens·2015
Same journal

A novel HLA-A*02 variant, HLA-A*02:575, detected in a Taiwanese bone marrow hematopoietic stem cell donor.

Tissue antigens·2015
See all related articles

Testing for HLA-B*5701, a gene linked to abacavir hypersensitivity (ABC HSR), prevents reactions. A new PCR-SSP method accurately detects HLA-B*5701, improving patient safety.

Area of Science:

  • Pharmacogenomics
  • Immunogenetics
  • Molecular Diagnostics

Background:

  • Abacavir hypersensitivity (ABC HSR) is a severe adverse drug reaction strongly associated with the HLA-B*5701 allele.
  • Prospective screening for HLA-B*5701 has proven effective in preventing ABC HSR, reducing incidence to 0% in screened populations.
  • Current detection methods like serological tests lack specificity for subtypes, while sequence-based typing (SBT) is costly and not universally accessible.

Purpose of the Study:

  • To develop and validate a rapid, accurate, and cost-effective alternative method for detecting the HLA-B*5701 allele.
  • To assess the specificity and sensitivity of the developed method in distinguishing HLA-B*5701 from closely related alleles.

Main Methods:

  • Development of a multiplexed polymerase chain reaction-sequence-specific primers (PCR-SSP) typing assay.

Related Experiment Videos

  • Validation of the PCR-SSP assay against sequence-based typing (SBT) for known HLA-B*5701 and related alleles.
  • Testing the assay's ability to differentiate HLA-B*5701 from other HLA-B57 subtypes and non-HLA-B*57 alleles.

    • Main Results:

    • The developed PCR-SSP method demonstrated high concordance with SBT for HLA-B*5701 allele identification.
    • The assay successfully distinguished HLA-B*5701 from closely related alleles such as HLA-B*5702, -B*5703, and -B*5704.
    • The multiplexed SSP assay showed high specificity, sensitivity, and reproducibility in typing various HLA-B alleles.

    Conclusions:

    • The developed PCR-SSP typing method offers a rapid, accurate, and reproducible means for detecting HLA-B*5701.
    • This method provides a valuable alternative for laboratories where SBT is not readily available, facilitating safer abacavir prescribing.
    • Improved diagnostic tools for HLA-B*5701 detection can enhance patient safety and pharmacogenomic screening strategies.